complex generics | AlphaStreet

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

February 13, 2025February 17, 2025

Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3 earnings call

Piramal Pharma Ltd Q2FY25; 360% rise in Profits

October 29, 2024

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1) Contract development

Categories